Proteomics International Laboratories Ltd (ASX:PIQ)
Australia
· Delayed Price · Currency is AUD 0.325
-0.005 (-1.52%)
At close: Mar 6, 2026
ASX:PIQ Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Operating Revenue | 0.81 | 0.96 | 0.89 | 0.73 | 1.49 | 1.31 | Upgrade
|
| Other Revenue | 2.4 | 2.35 | 2.38 | 2.45 | 1.94 | 1.42 | Upgrade
|
| Revenue | 3.21 | 3.31 | 3.27 | 3.18 | 3.43 | 2.74 | Upgrade
|
| Revenue Growth (YoY) | -8.11% | 1.34% | 2.75% | -7.26% | 25.39% | 0.25% | Upgrade
|
| Cost of Revenue | 2.74 | 2.22 | 2.02 | 2.35 | 2.06 | 0.81 | Upgrade
|
| Gross Profit | 0.46 | 1.09 | 1.25 | 0.84 | 1.37 | 1.92 | Upgrade
|
| Selling, General & Admin | 8.06 | 6.94 | 5.88 | 5.82 | 4.91 | 3.77 | Upgrade
|
| Other Operating Expenses | 1 | 1.02 | 0.61 | 0.53 | 0.51 | 0.71 | Upgrade
|
| Operating Expenses | 10.24 | 9.36 | 8 | 7.2 | 6.35 | 5 | Upgrade
|
| Operating Income | -9.78 | -8.27 | -6.75 | -6.37 | -4.98 | -3.08 | Upgrade
|
| Interest Expense | -0.04 | -0.04 | -0.02 | - | -0 | -0.01 | Upgrade
|
| Interest & Investment Income | 0.21 | 0.2 | 0.28 | 0.14 | 0.01 | 0.01 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.05 | -0.04 | -0.01 | -0.02 | 0 | -0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.06 | - | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -9.72 | -8.15 | -6.5 | -6.25 | -4.97 | -3.1 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 0.02 | 0.01 | - | 0.01 | Upgrade
|
| Other Unusual Items | - | - | - | - | - | 0.23 | Upgrade
|
| Pretax Income | -9.72 | -8.15 | -6.48 | -6.23 | -4.97 | -2.86 | Upgrade
|
| Earnings From Continuing Operations | -9.72 | -8.15 | -6.48 | -6.23 | -4.97 | -2.86 | Upgrade
|
| Minority Interest in Earnings | 0.06 | 0.04 | 0.11 | 0.06 | - | - | Upgrade
|
| Net Income | -9.66 | -8.11 | -6.38 | -6.18 | -4.97 | -2.86 | Upgrade
|
| Net Income to Common | -9.66 | -8.11 | -6.38 | -6.18 | -4.97 | -2.86 | Upgrade
|
| Shares Outstanding (Basic) | 135 | 134 | 126 | 116 | 106 | 102 | Upgrade
|
| Shares Outstanding (Diluted) | 135 | 134 | 126 | 116 | 106 | 102 | Upgrade
|
| Shares Change (YoY) | -2.35% | 6.69% | 8.07% | 10.35% | 3.76% | 16.34% | Upgrade
|
| EPS (Basic) | -0.07 | -0.06 | -0.05 | -0.05 | -0.05 | -0.03 | Upgrade
|
| EPS (Diluted) | -0.07 | -0.06 | -0.05 | -0.05 | -0.05 | -0.03 | Upgrade
|
| Free Cash Flow | -8.41 | -6.63 | -6 | -6.91 | -3.67 | -2.41 | Upgrade
|
| Free Cash Flow Per Share | -0.06 | -0.05 | -0.05 | -0.06 | -0.04 | -0.02 | Upgrade
|
| Gross Margin | 14.37% | 32.95% | 38.34% | 26.27% | 40.01% | 70.25% | Upgrade
|
| Operating Margin | -305.00% | -249.57% | -206.46% | -200.11% | -145.10% | -112.68% | Upgrade
|
| Profit Margin | -301.26% | -244.98% | -195.08% | -194.17% | -144.98% | -104.53% | Upgrade
|
| Free Cash Flow Margin | -262.54% | -200.28% | -183.46% | -217.25% | -106.97% | -88.25% | Upgrade
|
| EBITDA | -9.51 | -7.79 | -6.12 | -5.84 | -4.56 | -2.77 | Upgrade
|
| EBITDA Margin | -296.78% | -235.19% | -187.28% | -183.46% | -132.95% | -101.40% | Upgrade
|
| D&A For EBITDA | 0.26 | 0.48 | 0.63 | 0.53 | 0.42 | 0.31 | Upgrade
|
| EBIT | -9.78 | -8.27 | -6.75 | -6.37 | -4.98 | -3.08 | Upgrade
|
| EBIT Margin | - | -249.57% | -206.46% | -200.11% | -145.10% | -112.68% | Upgrade
|
| Revenue as Reported | 3.42 | 3.51 | 3.57 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.